Advertisement
Abstract| Volume 60, ISSUE 4, PS8-S9, April 2007

CYP1B1 expression in malignant melanoma: A potential molecular target

      Introduction and Aims: Melanoma is resistant to standard chemotherapies and few therapeutic measures improve patient survival in the metastatic stage of the disease. CYP1B1, a member of the cytochrome P450 enzyme family, appears to be over-expressed in a number of human malignancies whilst exhibiting little protein expression in normal tissues. CYP1B1 protein expression was investigated in primary and metastatic melanoma to assess its potential as a target for pro-drug therapy.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Plastic, Reconstructive & Aesthetic Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect